Acurx Pharmaceuticals (ACXP) Earnings Date & Reports

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACXP is expected to report earnings to rise 354.55% to -50 cents per share on August 18

Acurx Pharmaceuticals ACXP Stock Earnings Reports

Q2'25

Est.

$-0.50

Q1'25

Beat

by $0.27

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.02

Q2'24

Missed

by $0.09

The last earnings report on May 13 showed earnings per share of -10 cents, beating the estimate of -37 cents. With 95.75K shares outstanding, the current market capitalization sits at 8.37M.

View a ticker or compare two or three

Compare

ACXP